浩欧博: 江苏浩欧博生物医药股份有限公司关于自愿披露全资子公司获得医疗器械注册证的公告

Core Viewpoint - Jiangsu Haooubo Biopharmaceutical Co., Ltd. announced that its wholly-owned subsidiary, Hunan Haooubo Biopharmaceutical Co., Ltd., has recently obtained three medical device registration certificates from the Hunan Provincial Drug Administration, enhancing its product offerings in the allergy testing market [1][2]. Group 1: Medical Device Registration - The company received three medical device registration certificates for allergy testing kits, which include: 1. A kit for quantitative detection of specific IgE antibodies for ragweed allergy [1]. 2. A kit for qualitative detection of specific IgE antibodies for food allergens [2]. 3. A kit for qualitative detection of specific IgE antibodies for inhalant allergens [2]. Group 2: Impact on the Company - The acquisition of these medical device registration certificates enriches the company's chemiluminescence platform testing menu, which is expected to enhance its market competitiveness and positively influence the sustainable development of the company and its subsidiaries [3].